Breaking News Instant updates and real-time market news.

2020-02-26 06:00:02 ICPT Intercept $84.52 / -6.25 (-6.89%) , CBAY CymaBay $1.65 / -0.045 (-2.65%) 06:00 02/26/20 02/26 06:00 02/26/20 06:00	Citi upgrades Intercept to Buy on peak sales potential of Ocaliva Citi analyst Joel Beatty upgraded Intercept Pharmaceuticals (ICPT) to Buy from Neutral with a price target of $125, down from $140. The analyst continues to see "significant risk" that the first couple of years of Ocaliva's launch in nonalcoholic steatohepatitis will be slow, and his base case is that a large number of payers will place barriers, such as requiring a biopsy for diagnosis, early on. However, beyond this time frame, Beatty is confident that non-invasive diagnostics will go on to be widely accepted for NASH. As such, Ocaliva's peak sales potential "remains strong and supports buying the stock at the current price," contends Beatty. In addition, the discontinuation of development of CymaBay's seladelpar late last year gives the analyst more confidence that primary biliary cholangitis revenues for Ocaliva "can be largely maintained for now." ICPT Intercept $84.52 / -6.25 (-6.89%) CBAY CymaBay $1.65 / -0.045 (-2.65%)	05 Mar 26 Mar 22 Apr 26 Jun
ICPT CBAY ICPT Intercept $84.52 / -6.25 (-6.89%) 02/26/20 Citi Intercept upgraded to Buy from Neutral at Citi 02/21/20 SVB Leerink Intercept upgraded to Market Perform from Underperform at SVB Leerink 01/17/20 JMP Securities JMP says Intercept's new PDUFA date consistent with adjusted timelines 01/09/20 B. Riley Securities Arbutus Biopharma price target raised to $6 from $3 at B. Riley FBR CBAY CymaBay $1.65 / -0.045 (-2.65%) 01/02/20 Citi Intercept downgraded to Neutral from Buy at Citi 12/20/19 H.C. Wainwright H.C. Wainwright pulls CymaBay price target amid restructuring 11/26/19 H.C. Wainwright Favorable safety a positive for Genfit's elafibranor, says H.C. Wainwright 11/26/19 Fly Intel: Top five analyst downgrades

2020-02-26 06:00:02

ICPT

Intercept

$84.52 / -6.25 (-6.89%)

, CBAY

CymaBay

$1.65 / -0.045 (-2.65%)

06:00

02/26/20

02/26

06:00

02/26/20

06:00

Citi upgrades Intercept to Buy on peak sales potential of Ocaliva

Citi analyst Joel Beatty upgraded Intercept Pharmaceuticals (ICPT) to Buy from Neutral with a price target of $125, down from $140. The analyst continues to see "significant risk" that the first couple of years of Ocaliva's launch in nonalcoholic steatohepatitis will be slow, and his base case is that a large number of payers will place barriers, such as requiring a biopsy for diagnosis, early on. However, beyond this time frame, Beatty is confident that non-invasive diagnostics will go on to be widely accepted for NASH. As such, Ocaliva's peak sales potential "remains strong and supports buying the stock at the current price," contends Beatty. In addition, the discontinuation of development of CymaBay's seladelpar late last year gives the analyst more confidence that primary biliary cholangitis revenues for Ocaliva "can be largely maintained for now."

ICPT

Intercept

$84.52 / -6.25 (-6.89%)

CBAY

CymaBay

$1.65 / -0.045 (-2.65%)

05
Mar
26
Mar
22
Apr
26
Jun

ICPT
CBAY

ICPT Intercept

$84.52 / -6.25 (-6.89%)

02/26/20 Citi: Intercept upgraded to Buy from Neutral at Citi

02/21/20 SVB Leerink: Intercept upgraded to Market Perform from Underperform at SVB Leerink

01/17/20 JMP Securities: JMP says Intercept's new PDUFA date consistent with adjusted timelines

01/09/20 B. Riley Securities: Arbutus Biopharma price target raised to $6 from $3 at B. Riley FBR

CBAY CymaBay

$1.65 / -0.045 (-2.65%)

01/02/20 Citi: Intercept downgraded to Neutral from Buy at Citi

12/20/19 H.C. Wainwright: H.C. Wainwright pulls CymaBay price target amid restructuring

11/26/19 H.C. Wainwright: Favorable safety a positive for Genfit's elafibranor, says H.C. Wainwright

11/26/19: Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Recommendations	Park Lawn price target raised to C$40 from C$33.50 at National Bank » 12:23 03/02/21 03/02 12:23 03/02/21 12:23 PRRWF Park Lawn $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PRRWF Park Lawn $0.00 / + (+0.00%) 02/17/21 Stifel Park Lawn price target raised to C$40.25 from C$35.50 at Stifel 12/16/20 National Bank Park Lawn price target lowered to C$33.50 from C$35.50 at National Bank 11/30/20 RBC Capital Park Lawn initiated with an Outperform at RBC Capital 11/16/20 National Bank Park Lawn price target raised to C$35.50 from C$35 at National Bank
Conference/Events	UBS derivatives analyst to hold an analyst/industry conference call » 12:19 03/02/21 03/02 12:19 03/02/21 12:19 Head of Americas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 12:17 03/02/21 03/02 12:17 03/02/21 12:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/01/21 NASDAQ market internals summary 03/01/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 12:16 03/02/21 03/02 12:16 03/02/21 12:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/01/21 NYSE market internals summary 03/01/21 NYSE market internals summary
General news	Treasury Action: Treasury yields are being tugged lower » 12:10 03/02/21 03/02 12:10 03/02/21 12:10 Treasury Action: Treasury… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Hot Stocks	Epizyme expects cash to fund initiatives into 2023 » 12:07 03/02/21 03/02 12:07 03/02/21 12:07 EPZM Epizyme $9.65 / -0.13 (-1.33%) The company reiterated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:06 Today Epizyme plans to submit IND application for SETD2 in mid-2021 12:05 Today Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Hot Stocks	Epizyme plans to submit IND application for SETD2 in mid-2021 » 12:06 03/02/21 03/02 12:06 03/02/21 12:06 EPZM Epizyme $9.65 / -0.13 (-1.33%) SETD2 is a histone… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:05 Today Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Periodicals	Xpeng to offer cheaper battery option for P7 model in China, SCMP reports » 12:06 03/02/21 03/02 12:06 03/02/21 12:06 XPEV Xpeng $32.59 / -2.905 (-8.18%) , TSLA Tesla $704.20 / -14.53 (-2.02%) Xpeng (XPEV), which is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 05:41 Today Xpeng delivers 2.223 Smart EVs in February 02/22/21 Xpeng guided pilot function used for over 1M kilometers since launch 02/01/21 Xpeng delivers 6,015 Smart EVs in January, up 470% 01/26/21 Xpeng announces 'major over-the-air upgrade' for P7 sedan owners in China TSLA Tesla $704.20 / -14.53 (-2.02%) 02/17/21 Cathie Wood says ARK adding to positions in Tesla 02/17/21 EU passenger car registrations down 24.0% in January 02/11/21 EVgo extends nation's largest fast charging network to Tesla drivers 02/10/21 Tesla director Kimbal Musk sells $25.6M in common stock XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 01/28/21 Morgan Stanley starts Xpeng at Overweight on in-house R&D, market potential 01/28/21 Morgan Stanley Xpeng initiated with an Overweight at Morgan Stanley 01/21/21 Deutsche Bank Deutsche puts short-term buy on Xpeng ahead of 'several catalysts' 01/21/21 Deutsche Bank Xpeng named 'Catalyst Call: Buy Idea' at Deutsche Bank TSLA Tesla $704.20 / -14.53 (-2.02%) 02/25/21 Wedbush Wedbush sees limited impact to Tesla from chip-driven factory shutdowns 02/22/21 Wedbush Wedbush estimates Tesla made roughly $1B on bitcoin investment 02/22/21 Argus Livent upgraded to Buy from Hold at Argus 02/16/21 Wedbush India factory 'a smart strategic move' by Tesla, says Wedbush XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 11/12/20 Xpeng sees Q4 revenue RMB 2.2B, up 244% year-over-year 11/12/20 Xpeng reports Q3 EPS (32c), deliveries of 8,578 TSLA Tesla $704.20 / -14.53 (-2.02%) 01/27/21 Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01 01/27/21 Notable companies reporting after market close 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 09 Dec 27 Aug XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 12/12/20 Nio, Xeng, Li Auto not the next Tesla, Barron's says 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 12/01/20 Lucid Motors finishes 1st part of construction on Arizona factory, Electrek says TSLA Tesla $704.20 / -14.53 (-2.02%) 06:20 Today Tesla still relying on supply outside China for Gigafactory 3, DigiTimes reports 02/25/21 Tesla to temporarily halt Model 3 line at California plant, Bloomberg reports 02/23/21 Lucid CEO tells Bloomberg production delay due to Churchill concerns 02/22/21 Tesla stops taking order for base Model Y SUV, Electrek reports XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal 02/01/21 Piper more than doubles Tesla target as EV competitors report delivery numbers 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: After-Hours Movers TSLA Tesla $704.20 / -14.53 (-2.02%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 03/08/21 Xpeng - XPEV XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 02/10/21 XPeng call volume above normal and directionally bullish 01/22/21 XPeng call volume above normal and directionally bullish 01/19/21 XPeng call volume above normal and directionally bullish 01/12/21 XPeng call volume above normal and directionally bullish TSLA Tesla $704.20 / -14.53 (-2.02%) 02/24/21 Notable open interest changes for February 24th 02/23/21 Notable open interest changes for February 23rd 02/22/21 Notable open interest changes for February 22nd 02/11/21 Notable open interest changes for February 11th
Hot Stocks	Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 » 12:05 03/02/21 03/02 12:05 03/02/21 12:05 EPZM Epizyme $9.65 / -0.13 (-1.33%) Epizyme will initiate two… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Options	Digital Turbine call volume above normal and directionally bullish » 12:05 03/02/21 03/02 12:05 03/02/21 12:05 APPS Digital Turbine $94.58 / -0.19 (-0.20%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/26/21 Digital Turbine to acquire AdColony for $350M-$375M 02/26/21 Digital Turbine to acquire AdColony from Otello Corp for $400M consideration 09/09/20 Digital Turbine CEO Stone sells 84,585 common shares APPS Digital Turbine $94.58 / -0.19 (-0.20%) 03/01/21 Craig-Hallum Digital Turbine price target raised to $90 from $80 at Craig-Hallum 03/01/21 Roth Capital Digital Turbine price target raised to $100 from $87 at Roth Capital 02/04/21 Craig-Hallum Digital Turbine price target raised to $80 from $60 at Craig-Hallum 02/04/21 Roth Capital Digital Turbine price target raised to $87 from $70 at Roth Capital APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/03/21 Digital Turbine sees FY21 adjusted EPS 67c, consensus 63c 02/03/21 Digital Turbine reports Q3 adjusted EPS 21c, consensus 17c 10/29/20 Digital Turbine sees Q3 non-GAAP EPS 15c-16c, consensus 12c 10/29/20 Digital Turbine sees Q3 non-GAAP EPS 15c-16c, consensus 12c APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/23/21 Digital Turbine call volume above normal and directionally bullish 02/03/21 Digital Turbine options imply 17.0% move in share price post-earnings 11/18/20 Unusually active option classes on open November 18th 11/05/20 Digital Turbine call volume above normal and directionally bullish

Hot Stocks	Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 » 12:04 03/02/21 03/02 12:04 03/02/21 12:04 EPZM Epizyme $9.65 / -0.13 (-1.33%) The combination of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Hot Stocks	Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 » 12:04 03/02/21 03/02 12:04 03/02/21 12:04 EPZM Epizyme $9.65 / -0.13 (-1.33%) The combination of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 10/07/20 Epizyme's Tazverik Phase 2 data featured in two Lancet Oncology publications EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Conference/Events	Net 1 UEPS participates in a conference call hosted by B. Riley Securities » 12:02 03/02/21 03/02 12:02 03/02/21 12:02 UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 02/09/21 Net 1 UEPS appoints Lincoln Mali as South African CEO 02/04/21 Net 1 UEPS sells remaining interest in Bank Frick for $30M UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 01/20/21 B. Riley Securities Net 1 UEPS price target raised to $7 from $5 at B. Riley Securities 09/15/20 B. Riley FBR Net 1 UEPS 'stands out as significantly undervalued,' says B. Riley FBR 09/08/20 B. Riley FBR Net 1 UEPS transferred with Buy rating, $5 target at B. Riley FBR UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 12/21/20 Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades 11/30/20 Fly Insider: Merrimack, Catalent among weeks notable insider trades 10/05/20 Fly Insider: Odonate Therapeutics, Carvana among week's notable insider trades 00:00 Today Net 1 UEPS - UEPS
Hot Stocks	CNH Industrial completes minority investment in Monarch Tractor » 12:02 03/02/21 03/02 12:02 03/02/21 12:02 CNHI CNH Industrial $14.91 / -0.13 (-0.86%) CNH Industrial announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/24/21 EU commercial vehicle registrations down 7.2% in January 01/26/21 EU commercial vehicle registrations down 4.2% in December 11/30/20 Accenture, Microsoft collaborate with CNH Industrial on connected vehicles 11/25/20 EU commercial vehicle registrations down 1.2% in October CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/18/21 Citi CNH Industrial resumed with a Buy at Citi 02/04/21 Vertical Research CNH Industrial upgraded to Buy from Hold at Vertical Research 01/20/21 Vertical Research CNH Industrial initiated with a Hold at Vertical Research 12/15/20 Stifel CNH Industrial price target raised to $12 from $9.50 at Stifel CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/03/21 CNH Industrial reports Q4 adjusted EPS 30c, consensus 14c 11/05/20 CNH Industrial reports Q3 adjusted EPS 11c, consensus 2c
Conference/Events	Alpha & Omega participates in a conference call hosted by B. Riley Securities » 12:01 03/02/21 03/02 12:01 03/02/21 12:01 AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 11/13/20 Alpha & Omega announces retirement of COO Dr. Yueh-se Ho AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/10/21 B. Riley Securities B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion 02/08/21 Loop Capital Alpha & Omega price target raised to $45 from $35 at Loop Capital 02/05/21 B. Riley Securities Alpha & Omega price target raised to $44 from $40 at B. Riley Securities 01/25/21 B. Riley Securities Alpha & Omega price target raised to $40 from $35 at B. Riley Securities AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/04/21 Alpha & Omega sees Q3 revenue approximately $157M plus or minus $3M 02/04/21 Alpha & Omega reports Q2 adjusted EPS 65c, consensus 54c 11/05/20 Alpha & Omega sees Q2 revenue $150M-$156M, consensus $141.4M. 11/05/20 Alpha & Omega reports Q1 EPS 55c, consensus 51c AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/04/21 Fly Intel: After-Hours Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 00:00 Today Alpha & Omega - AOSL

Conference/Events	Progressive to host investor conference call » 12:01 03/02/21 03/02 12:01 03/02/21 12:01 PGR Progressive $88.50 / +0.88 (+1.00%) Management hosts a 4th… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PGR Progressive $88.50 / +0.88 (+1.00%) 02/16/21 Progressive to acquire Protective Insurance for $23.30 per share in cash PGR Progressive $88.50 / +0.88 (+1.00%) 02/01/21 Deutsche Bank Progressive price target lowered to $105 from $108 at Deutsche Bank 01/13/21 Gordon Haskett Allstate lowering auto rates by 5% in several states, says Gordon Haskett 01/08/21 Goldman Sachs Progressive downgraded to Sell from Neutral at Goldman Sachs 01/07/21 B. Riley Securities Progressive price target raised to $96 from $88 at B. Riley Securities PGR Progressive $88.50 / +0.88 (+1.00%) 02/17/21 Progressive reports January EPS 95c vs. 52c last year 01/27/21 Progressive reports December EPS $1.20 vs. 78c last year 01/27/21 Progressive reports Q4 EPS $2.85, consensus $1.66 01/26/21 Notable companies reporting before tomorrow's open PGR Progressive $88.50 / +0.88 (+1.00%) 09/22/20 Amazon upgrade, PayPal initiation among today's top calls on Wall Street 13:00 Today Progressive - PGR 13:00 Today Progressive Corporation PGR Progressive $88.50 / +0.88 (+1.00%) 12/07/20 Early notable gainers among liquid option names on December 7th
Hot Stocks	C3.ai falls -14.0% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 AI C3.ai $104.12 / -16.66 (-13.79%) C3.ai is down -14.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options AI C3.ai $104.12 / -16.66 (-13.79%) 10:01 Today C3.ai falls -12.6% 09:47 Today C3.ai falls -11.9% 02/25/21 C3.ai awarded omnibus U.S. patent for end-to-end enterprise AI platform 02/01/21 Shell, C3, Baker Hughes, Microsoft launch Open AI Energy Initiative AI C3.ai $104.12 / -16.66 (-13.79%) 07:31 Today Canaccord C3.ai price target lowered to $120 from $140 at Canaccord 01/04/21 KeyBanc C3.ai initiated with a Sector Weight at KeyBanc 01/04/21 Wedbush Wedbush bullish on C3.ai, initiates with an Outperform 01/04/21 Canaccord C3.ai initiated with a Hold at Canaccord AI C3.ai $104.12 / -16.66 (-13.79%) 03/01/21 C3.ai reports Q3 EPS (13c), consensus (16c) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 09 Dec AI C3.ai $104.12 / -16.66 (-13.79%) 03/01/21 Fly Intel: After-Hours Movers 01/04/21 Fly Intel: Pre-market Movers 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut 09/23/20 Fly Intel: After-Hours Movers 00:00 Today Energy & Power Virtual Conference AI C3.ai $104.12 / -16.66 (-13.79%) 02/09/21 C3 AI call volume above normal and directionally bullish 02/02/21 C3 AI call volume above normal and directionally bullish 01/06/21 Largest borrow rate increases among liquid names 12/15/20 Two new option listings on December 15th
Hot Stocks	Switch falls -14.2% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 SWCH Switch $15.17 / -2.52 (-14.25%) Switch is down -14.2%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SWCH Switch $15.17 / -2.52 (-14.25%) 10:02 Today Switch falls -10.7% 09:47 Today Switch falls -11.3% 03/01/21 Switch drops about 7% to $16.51 after reporting mixed Q4 results 09/16/20 Switch appoints Angela Archon to Board of Directors, effective November 4 SWCH Switch $15.17 / -2.52 (-14.25%) 08:21 Today Raymond James Switch downgraded to Outperform from Strong Buy at Raymond James 04:44 Today Raymond James Switch downgraded to Outperform from Strong Buy at Raymond James 02/02/21 Truist sees Switch positioned for long-term growth, starts at Buy 02/02/21 Truist Switch initiated with a Buy at Truist SWCH Switch $15.17 / -2.52 (-14.25%) 03/01/21 Switch sees FY21 revenue $540M-$555M, consensus $588.3M 03/01/21 Switch reports Q4 adjusted EPS 6c, consensus 5c 11/05/20 Switch sees FY20 revenue $510M-$518M, consensus $516.47M 11/05/20 Switch reports Q3 EPS 5c, consensus 4c SWCH Switch $15.17 / -2.52 (-14.25%) 03/01/21 Fly Intel: After-Hours Movers
Hot Stocks	3D Systems falls -14.8% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 DDD 3D Systems $33.05 / -5.69 (-14.69%) 3D Systems is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DDD 3D Systems $33.05 / -5.69 (-14.69%) 03/01/21 3D Systems sees FY21 gross margin 40%-44% 02/24/21 3D Systems announces introduction of High Speed Fusion 3D printing system 02/11/21 3D Systems selected by Raytheon and DEVCOM as part of research project 02/03/21 3D Systems rises 16.2% DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/25/21 Fly Intel: Top five analyst downgrades 01/25/21 Berenberg 3D Systems downgraded to Hold from Buy at Berenberg DDD 3D Systems $33.05 / -5.69 (-14.69%) 03/01/21 3D Systems reports Q4 EPS 9c, consensus 10c 03/01/21 Notable companies reporting after market close 01/07/21 3D Systems sees Q4 revenue $170M-$176M, consensus $139.91M. 11/05/20 3D Systems reports Q3 EPS (3c), consensus (8c) DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street 01/15/21 Fly Intel: Pre-market Movers 01/07/21 Fly Intel: Wall Street's top stories for Thursday 01/07/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Industrial Technologies Virtual Conference 2021 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 08:30 Today 3D Systems - DDD DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/14/21 3D Systems call volume above normal and directionally bullish 01/07/21 3D Systems call volume above normal and directionally bullish 12/29/20 3D Systems put volume heavy and directionally bearish 12/17/20 3D Systems call volume above normal and directionally bullish
Hot Stocks	Fisker rises 15.0% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 FSR Fisker $31.68 / +4.32 (+15.79%) Fisker is up 15.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FSR Fisker $31.68 / +4.32 (+15.79%) 03/01/21 Fisker CEO tweets about passing 13,000 Ocean reservations 'fast!' 03/01/21 Fisker falls -9.3% 02/25/21 Fisker up 6% to $22.86 after Q4 report 02/25/21 Fisker sees FY21 operating expenses $210M-$240M FSR Fisker $31.68 / +4.32 (+15.79%) 02/26/21 Morgan Stanley Fisker price target raised to $40 from $27 at Morgan Stanley 02/26/21 Cowen Fisker price target raised to $29 from $22 at Cowen 02/17/21 R.F. Lafferty Fisker initiated with a Buy at R.F. Lafferty 02/11/21 Morgan Stanley Fisker initiated with an Overweight at Morgan Stanley FSR Fisker $31.68 / +4.32 (+15.79%) 02/25/21 Fisker reports Q4 EPS (5c), consensus (5c) 02/25/21 Notable companies reporting after market close FSR Fisker $31.68 / +4.32 (+15.79%) 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close 02/16/21 Churchill Capital Corp IV near deal to bring Lucid Motors public, Reuters says 01/26/21 Fisker rallies after Seeking Alpha contributor sees 1,000% long-term upside FSR Fisker $31.68 / +4.32 (+15.79%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Fly Intel: After-Hours Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday FSR Fisker $31.68 / +4.32 (+15.79%) 10:25 Today Fisker call volume above normal and directionally bullish 02/26/21 Fisker call volume above normal and directionally bullish 02/24/21 Fisker call volume above normal and directionally bullish 02/12/21 Fisker call volume above normal and directionally bullish

Hot Stocks	Hovnanian rises 18.6% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 HOV Hovnanian $70.12 / +10.7 (+18.01%) Hovnanian is up 18.6%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events HOV Hovnanian $70.12 / +10.7 (+18.01%) 09/04/20 Hovnanian falls -16.2% HOV Hovnanian $70.12 / +10.7 (+18.01%) 09:29 Today Hovnanian sees FY21 revenue $2.65B-$2.8B 09:29 Today Hovnanian sees Q2 revenue $700M-$750M 09:27 Today Hovnanian reports Q1 EPS $2.75 vs. ($1.49) a year ago 12/09/20 Hovnanian reports Q4 EPS $5.54 vs (30c) last year 11:00 Today Hovnanian - HOV 03/30/21 Hovnanian Enterprises Inc.
Hot Stocks	Rocket Companies rises 19.2% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 RKT Rocket Companies $29.00 / +4.7 (+19.34%) Rocket Companies is up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT Rocket Companies $29.00 / +4.7 (+19.34%) 10:00 Today Rocket Companies rises 18.7% 09:47 Today Rocket Companies rises 14.6% 02/25/21 Rocket Companies announces special dividend of $1.11 per share 02/25/21 Rocket Companies sees Q1 closed loan volume $98B-$103B RKT Rocket Companies $29.00 / +4.7 (+19.34%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations RKT Rocket Companies $29.00 / +4.7 (+19.34%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 06 Aug RKT Rocket Companies $29.00 / +4.7 (+19.34%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RKT Rocket Companies $29.00 / +4.7 (+19.34%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RKT Rocket Companies $29.00 / +4.7 (+19.34%) 09:40 Today Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings
Recommendations	Chorus Aviation price target raised to C$4.75 from C$4 at National Bank » 11:54 03/02/21 03/02 11:54 03/02/21 11:54 CHRRF Chorus Aviation $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CHRRF Chorus Aviation $0.00 / + (+0.00%) 12/23/20 Trudeau says Canada's suspension of passenger flights from UK extended CHRRF Chorus Aviation $0.00 / + (+0.00%) 11:08 Today TD Securities Chorus Aviation price target raised to C$6 from C$5.50 at TD Securities 02/22/21 CIBC Chorus Aviation price target lowered to C$5.25 from C$5.50 at CIBC 02/22/21 National Bank Chorus Aviation price target raised to C$4 from C$3.60 at National Bank 01/29/21 National Bank Chorus Aviation price target lowered to C$3.60 from C$3.70 at National Bank CHRRF Chorus Aviation $0.00 / + (+0.00%) 11/05/20 Canada close to aid package for airlines, Reuters reports
Recommendations	Telus price target raised to C$34 from C$32 at Scotiabank » 11:51 03/02/21 03/02 11:51 03/02/21 11:51 TU Telus $20.59 / +0.065 (+0.32%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TU Telus $20.59 / +0.065 (+0.32%) 02/09/21 Google Cloud, Telus announce strategic alliance 01/25/21 Telus sees 2020 Telus International revenue $1.54B-$1.58B 01/25/21 Telus International launches IPO Roadshow 01/12/21 Telus, RingCentral expand partnership TU Telus $20.59 / +0.065 (+0.32%) 03/01/21 Morgan Stanley Telus International initiated with an Equal Weight at Morgan Stanley 02/12/21 National Bank Telus price target raised to C$29 from C$28 at National Bank 02/12/21 BMO Capital Telus price target raised to C$30 from C$26 at BMO Capital 02/12/21 RBC Capital Telus price target raised to C$29 from C$28 at RBC Capital TU Telus $20.59 / +0.065 (+0.32%) 01/25/21 Telus sees Q4 Telus International revenue $430M-$445M TU Telus $20.59 / +0.065 (+0.32%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 01/25/21 Fly Intel: Pre-market Movers
Periodicals	New Apple Card users get 6% Daily Cash on Apple purchases, 9to5Mac says » 11:50 03/02/21 03/02 11:50 03/02/21 11:50 AAPL Apple $125.81 / -1.96 (-1.53%) Apple is offering new… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $125.81 / -1.96 (-1.53%) 02/25/21 Target announces enhanced Apple shopping experience for customers 02/19/21 Luminar, Velodyne Lidar move up after Bloomberg says Apple looking at LiDAR 02/19/21 Energous jumps 53% on Bloomberg report that Apple is working on battery pack 02/18/21 Zynga, Lucasfilm Games announce Star Wars: Hunters for Nintendo Switch AAPL Apple $125.81 / -1.96 (-1.53%) 03/01/21 Wedbush Asia checks bullish for Apple iPhone 12 builds, says Wedbush 03/01/21 JPMorgan Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan 02/25/21 JPMorgan JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts 02/24/21 Piper Sandler Piper sees Apple developing 'full-blown' branded electric vehicle AAPL Apple $125.81 / -1.96 (-1.53%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year AAPL Apple $125.81 / -1.96 (-1.53%) 03/01/21 New EU 'Right to Repair' rules require goods to be repairable, Independent says 03/01/21 All Apple stores in U.S. open for first time since pandemic, CNBC reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/24/21 DOJ investigating Apple's use of 'Sign in With Apple' button, Information says AAPL Apple $125.81 / -1.96 (-1.53%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/19/21 Fly Intel: Wall Street's top stories for Friday 03/17/21 Technology AAPL Apple $125.81 / -1.96 (-1.53%) 08:55 Today Notable open interest changes for March 2nd 08:00 Today Apple call buyer realizes 91% same-day gains 03/01/21 Notable open interest changes for March 1st 02/26/21 Notable open interest changes for February 26th

Events

Earnings calls, analyst events, roadshows and more

PS
Today at 12:30

Pluralsight, Inc. Firm Sponsored Meetings
Today at 13:00

Fed Governor Speaks on US Economic Outlook Government Event

Virtual Evemt
PGR
Today at 13:00

Progressive - PGR Conference Calls
WORK
Today at 13:00

Slack Technologies, Inc. Firm Sponsored Meetings
PGR
Today at 13:00

Progressive Corporation Firm Sponsored Meetings

Virtual Meeting
SNOW
Today at 13:00

Software & Internet Industry Meetings
Today at 13:00

Consumer Goods Industry Meetings
Today at 14:00

Fed Reserve Bank of San Francisco President Speaks Government Event

Virtual Evemt
CCOI
Today at 14:00

Cogent - CCOI Conference Calls
Today at 14:00

Technology Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Citi upgrades Intercept to Buy on peak sales potential of Ocaliva

TODAY'S FREE FLY STORIES

Get Full Fly Access